Panagora Asset Management’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-29,512
Closed -$813K 2821
2021
Q2
$813K Sell
29,512
-6,747
-19% -$133K ﹤0.01% 1100
2021
Q1
$598K Buy
+36,259
New +$826K ﹤0.01% 1252

Panagora Asset Management's TBIO Position: Q3 2021 in Review

Panagora Asset Management sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 29,512 shares — an estimated $813K sold.

Panagora Asset Management first reported a position in TBIO in Q1 2021 and held it in 2 quarters. The position peaked at $813K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • Panagora Asset Management reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Panagora Asset Management sold 29,512 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $813K.
  • Panagora Asset Management first reported a position in Translate Bio, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • Panagora Asset Management's Translate Bio, Inc. Common Stock position peaked at $813K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Panagora Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.